KERENDIA

This brand name is authorized in United States. It is also authorized in Croatia, Estonia, Finland, Israel, Italy, Japan, Lithuania, Poland, Romania.

Active ingredients

The drug KERENDIA contains one active pharmaceutical ingredient (API):

1	Finerenone UNII DE2O63YV8R - FINERENONE
	Finerenone is a nonsteroidal, selective antagonist of the mineralocorticoid receptor (MR) which is activated by aldosterone and cortisol and regulates gene transcription. Its binding to the MR leads to a specific receptor-ligand complex that blocks recruitment of transcriptional coactivators implicated in the expression of pro-inflammatory and pro-fibrotic mediators.
	Read more about Finerenone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KERENDIA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03DA05		C Cardiovascular system → C03 Diuretics → C03D Potassium-sparing agents → C03DA Aldosterone antagonists
Discover more medicines within C03DA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1876170, 1876181, 1876192, 1876204, 1876215, 1876226, 1876237, 1876248, 1876259, 1876260, 1876271, 1876282
FI	Lääkealan turvallisuus- ja kehittämiskeskus	066372, 087492, 524798, 554185
IL	מִשְׂרַד הַבְּרִיאוּת	9212, 9213
IT	Agenzia del Farmaco	049927015, 049927027, 049927039, 049927041, 049927054, 049927066, 049927078, 049927080, 049927092, 049927104
JP	医薬品医療機器総合機構	2190044F1020, 2190044F2027
LT	Valstybinė vaistų kontrolės tarnyba	1094270, 1094271, 1094272, 1094273, 1094274, 1094275, 1094276, 1094277, 1094278, 1094279
PL	Rejestru Produktów Leczniczych	100465400, 100465424
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69353001, W69354001
US	FDA, National Drug Code	50419-540, 50419-541